Spartan Planning & Wealth Management Purchases Shares of 5,713 The Procter & Gamble Company (NYSE:PG)

Spartan Planning & Wealth Management purchased a new position in shares of The Procter & Gamble Company (NYSE:PG) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 5,713 shares of the company’s stock, valued at approximately $958,000. Procter & Gamble makes up 0.9% of Spartan Planning & Wealth Management’s investment portfolio, making the stock its 26th largest position.

Several other large investors also recently made changes to their positions in PG. Fiera Capital Corp grew its stake in Procter & Gamble by 1,135.1% in the second quarter. Fiera Capital Corp now owns 20,688 shares of the company’s stock valued at $3,412,000 after acquiring an additional 19,013 shares during the period. Strategic Financial Concepts LLC lifted its holdings in Procter & Gamble by 391.8% during the 2nd quarter. Strategic Financial Concepts LLC now owns 289,175 shares of the company’s stock worth $477,000 after purchasing an additional 230,374 shares during the last quarter. Chris Bulman Inc acquired a new position in Procter & Gamble in the 2nd quarter valued at $68,000. Adapt Wealth Advisors LLC increased its position in Procter & Gamble by 22.7% during the 2nd quarter. Adapt Wealth Advisors LLC now owns 2,560 shares of the company’s stock worth $422,000 after buying an additional 474 shares during the period. Finally, Quest Partners LLC bought a new stake in shares of Procter & Gamble in the second quarter valued at about $36,000. Institutional investors own 65.77% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on PG shares. Wells Fargo & Company reduced their price target on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a report on Tuesday. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research report on Monday, September 30th. Morgan Stanley boosted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Finally, Piper Sandler initiated coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $179.75.

Procter & Gamble Stock Performance

Shares of NYSE PG traded up $0.70 during midday trading on Tuesday, reaching $161.30. The company’s stock had a trading volume of 4,063,602 shares, compared to its average volume of 5,820,512. The stock has a market capitalization of $379.87 billion, a P/E ratio of 27.81, a PEG ratio of 3.70 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm has a 50 day moving average price of $170.03 and a 200-day moving average price of $169.80. The Procter & Gamble Company has a 12-month low of $146.28 and a 12-month high of $180.43.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s revenue for the quarter was down .6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.83 EPS. As a group, equities analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the sale, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. The trade was a 12.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 75,439 shares of company stock valued at $13,317,460. 0.18% of the stock is owned by company insiders.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.